| Literature DB >> 32149114 |
Kurt Ruetzler1, Lukasz Szarpak2, Jacek Smereka3, Marek Dabrowski4, Szymon Bialka5, Lauretta Mosteller6, Agnieszka Szarpak7, Kobi Ludwin7, Marzena Wojewodzka-Zelezniakowicz8, Jerzy Robert Ladny8.
Abstract
Introduction. Airway management plays an essential role in anaesthesia practice, during both elective and urgent surgery procedures and emergency medicine. AIM: The aim of the study was to compare Macintosh laryngoscope (MAC), McGrath, and TruView PCD in 5 separate airway management scenarios.Entities:
Mesh:
Year: 2020 PMID: 32149114 PMCID: PMC7049447 DOI: 10.1155/2020/5382739
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1Laryngoscopes used in this study: (a) Macintosh laryngoscope; (b) McGrath MAC video laryngoscope; (c) TruView PCD video laryngoscope.
Intubation details in scenario A normal airway. Data are presented as median (IQR) or as number (%).
| Parameter | A | B | C |
|
| ||
|---|---|---|---|---|---|---|---|
| Macintosh | McGrath | TruView PCD | A versus B | A versus C | B versus C | ||
|
| 92 (99%) | 93 (100%) | 87 (94%) | 0.127 | 0.644 | 0.761 | 0.011 |
|
| |||||||
|
| 17 (16–21) | 18 (16–21) | 27 (23–34) | 1.0 |
|
|
|
|
| |||||||
|
| 87 (94%) | 93 (100%) | 93 | 1.0 | 1.0 | 1.0 | 1.0 |
| 1 | 6 (7%) | 0 (0%) | (100%) | ||||
| 2 | 0 (0%) | 0 (0%) | 0 (0%) | ||||
| 3 | 0 (0%) | 0 (0%) | 0 (0%) | ||||
| 4 | 1 (1–1) | 1 (1–1) | 0 (0%) | ||||
| Median (IQR) | 1 (1–1) | ||||||
|
| |||||||
|
| 81 (78–100) | 100 (95–100) | 100 (90–100) |
|
| 1.0 |
|
|
| |||||||
|
| 84 (90%) | 92 (99%) | 76 | 1.0 | 1.0 | 0.561 | 0.982 |
| 0 | 9 (10%) | 1 (1 %) | (81%) | ||||
| 1 | 0 (0%) | 0 (0%) | 16 (19%) | ||||
| 2 | 0 (0–0) | 0 (0–0) | 1 (1%) | ||||
| Median (IQR) | 0 (0–0) | ||||||
|
| |||||||
|
| 36 (39%) | 48 (52%) | 2 (2%) | 0.770 |
|
|
|
| 0 | 57 (61%) | 45 (48%) | 20 | ||||
| 1 | 0 (0%) | 0 (0%) | (22%) | ||||
| 2 | 1 (0–1) | 0 (0–1) | 71 | ||||
| Median (IQR) | (76%) 2 (2–2) | ||||||
|
| |||||||
|
| 24 (10–27) | 20 (11–23) | 31 (17–35) | 0.671 |
|
|
|
Intubation details in scenario B tongue oedema. Data are presented as median (IQR) or as number (%).
| Parameter | A | B | C |
|
| ||
|---|---|---|---|---|---|---|---|
| Macintosh | McGrath | TruView PCD | A versus B | A versus C | B versus C | ||
|
| 57 (61%) | 90 (97%) | 90 (97%) |
|
| 1.0 |
|
|
| |||||||
|
| 44 (24–46) | 22 (20–27) | 39 (30–57) | 0.822 | 0.392 | 0.138 | 0.126 |
|
| |||||||
|
| 0 (0%) | 77 (83%) | 70 (75%) |
|
| 1.0 |
|
| 1 | 3 (3%) | 16 (17%) | 23 (25%) | ||||
| 2 | 86 (93%) | 0 (0%) | 0 (0%) | ||||
| 3 | 4 (4%) | 0 (0%) | 0 (0%) | ||||
| 4 | 3 (3–3) | 1 (1–1) | 1 (1–1) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 37 (29–49) | 93 (80–100) | 90 (82–95) |
|
| 0.117 |
|
|
| |||||||
|
| 0 (0%) | 19 (20%) | 0 (0%) |
| 1.0 |
|
|
| 0 | 17 (19%) | 29 (31%) | 14 (18%) | ||||
| 1 | 76 (81%) | 45 (48%) | 79 (82%) | ||||
| 2 | 2 (2–2) | 1 (1–2) | 2 (2–2) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
|
| 1.0 |
|
| |||
| 0 | 0 (0%) | 40 (43%) | 0 (0%) | ||||
| 1 | 12 (13%) | 44 (47%) | 20 (22%) | ||||
| 2 | 81 (87%) | 9 (10%) | 73 (79%) | ||||
| Median (IQR) | 2 (2–2) | 1 (0–1) | 2 (2–2) | ||||
|
| |||||||
|
| 74 (50–80) | 34 (26–47) | 46 (38–61) |
|
|
|
|
Intubation details in scenario C pharyngeal obstruction. Data are presented as median (IQR) or as number (%).
| Parameter | A | B | C |
|
| ||
|---|---|---|---|---|---|---|---|
| Macintosh | McGrath | TruView PCD | A versus B | A versus C | B versus C | ||
|
| 69 (74%) | 90 (97%) | 67 (72%) |
| 1.0 |
|
|
|
| |||||||
|
| 21 (19–29) | 18 (18–25) | 30 (23–39) |
|
|
|
|
|
| |||||||
|
| 82 (88%) | 93 (100%) | 92 (99%) | 1.0 | 1.0 | 1.0 | 1.0 |
| 1 | 11 (12%) | 0 (0%) | 1 (1%) | ||||
| 2 | 0 (0%) | 0 (0%) | 0 (0%) | ||||
| 3 | 0 (0%) | 0 (0%) | 0 (0%) | ||||
| 4 | 1 (1–1) | 1 (1–1) | 1 (1–1) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 80 (78–100) | 100 (95–100) | 100 (84–100) |
|
| 0.817 |
|
|
| |||||||
|
| 73 (79%) | 92 (99%) | 39 (42%) |
|
|
|
|
| 0 | 6 (7%) | 1 (1%) | 46 (50%) | ||||
| 1 | 14 (15.0%) | 0 (0%) | 8 (9%) | ||||
| 2 | 0 (0–0) | 0 (0–0) | 1 (0–1) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 21 (23%) | 37 (40%) | 2 (2%) |
|
|
|
|
| 0 | 53 (57%) | 53 (57%) | 41 (44%) | ||||
| 1 | 19 (21%) | 3 (3%) | 50 (54%) | ||||
| 2 | 1 (1–1) | 1 (0–1) | 2 (1–2) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 27 (14–38) | 20 (11–24) | 39 (24–49) |
|
|
|
|
Intubation details in scenario D cervical collar stabilization and tongue oedema. Data are presented as median (IQR) or as number (%).
| Parameter | A | B | C |
|
| ||
|---|---|---|---|---|---|---|---|
| Macintosh | McGrath | TruView PCD | A versus B | A versus C | B versus C | ||
|
| 30 (32%) | 64 (69%) | 58 (62%) |
|
| 1.0 |
|
|
| |||||||
|
| 54 (39–71) | 26 (20–29) | 45 (33–56) |
|
|
|
|
|
| |||||||
|
| 0 (0%) | 64 (69%) | 50 (54%) |
|
| 0.798 |
|
| 1 | 3 (3%) | 29 (31%) | 43 (46%) | ||||
| 2 | 71 (76%) | 0 (0%) | 0 (0%) | ||||
| 3 | 19 (21%) | 0 (0%) | 0 (0%) | ||||
| 4 | 3 (3–3) | 1 (1–2) | 1 (1–2) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 35 (29–42) | 86 (75–94) | 80 (75–91) |
|
| 0.725 |
|
|
| |||||||
|
| 4 (4%) | 11 (12%) | 1 (1%) |
|
|
|
|
| 0 | 10 (20%) | 47 (51%) | 39 (42%) | ||||
| 1 | 79 (85%) | 35 (38%) | 533 (57%) | ||||
| 2 | 2 (2–2) | 1 (1–2) | 2 (1–2) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 0 (0%) | 0 (0%) | 0 (0%) |
| 0.489 |
|
|
| 0 | 2 (2%) | 76 (82%) | 13 (14%) | ||||
| 1 | 91 (98%) | 17 (18%) | 80 (86%) | ||||
| 2 | 2 (2–2) | 1 (1–1) | 2 (2–2) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 81 (63–90) | 34 (28–48) | 57 (45–75) |
|
|
|
|
Intubation details in scenario E cervical collar stabilization and pharyngeal obstruction. Data are presented as median (IQR) or as number (%).
| Parameter | A | B | C |
|
| ||
|---|---|---|---|---|---|---|---|
| Macintosh | McGrath | TruView PCD | A versus B | A versus C | B versus C | ||
|
| 14 (15%) | 87 (94%) | 53 (57%) |
|
|
|
|
|
| |||||||
|
| 28 (25–39) | 19 (18–26) | 34 (27–45) |
| 0.787 |
|
|
|
| |||||||
|
| 0 (0%) | 79 (84%) | 40 (43%) |
|
|
|
|
| 1 | 31 (33%) | 14 (16%) | 53 (57%) | ||||
| 2 | 58 (62%) | 0 (0%) | 0 (0%) | ||||
| 3 | 4 (4%) | 0 (0%) | 0 (0%) | ||||
| 4 | 3 (2–3) | 1 (1–1) | 1 (1–2) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 45 (29–63) | 98 (90–100) | 92 (83–98) |
|
|
|
|
|
| |||||||
|
| 10 (11%) | 31 (33%) | 19 (20%) |
|
|
|
|
| 0 | 21 (23%) | 45 (48%) | 37 (40%) | ||||
| 1 | 62 (67%) | 17 (18%) | 37 (40%) | ||||
| 2 | 2 (1–2) | 1 (0–1) | 1 (1–2) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 0 (0%) | 0 (0%) | 0 (0%) |
|
|
|
|
| 0 | 7 (8%) | 90 (97%) | 31 (33%) | ||||
| 1 | 86 (93%) | 3 (3%) | 62 (67%) | ||||
| 2 | 2 (2–2) | 1 (1–1) | 2 (1–2) | ||||
| Median (IQR) | |||||||
|
| |||||||
|
| 68 (51–80) | 31 (28–45) | 51 (36–64) |
|
|
|
|